OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study
Jia Peng, Mingming Liu, Jing‐Lu Jin, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Liver disease is a significant risk factor for cardiovascular outcomes – A UK Biobank study
Adriana Roca‐Fernández, Rajarshi Banerjee, Helena Thomaides‐Brears, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1085-1095
Open Access | Times Cited: 56

A promising therapy for fatty liver disease: PCSK9 inhibitors
Lizhu Han, Liuyun Wu, Qinan Yin, et al.
Phytomedicine (2024) Vol. 128, pp. 155505-155505
Closed Access | Times Cited: 9

PCSK9 Enhances Cardiac Fibrogenesis via the Activation of Toll-like Receptor and NLRP3 Inflammasome Signaling
Cheng‐Chih Chung, Yu‐Hsun Kao, Yao‐Chang Chen, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1921-1921
Open Access

Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review
Kim Oren Gradel
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6132-6132
Open Access | Times Cited: 12

Anti-PCSK9 Treatment Attenuates Liver Fibrosis via Inhibiting Hypoxia-Induced Autophagy in Hepatocytes
Liuxin Ning, Yanting Zou, Shuyu Li, et al.
Inflammation (2023) Vol. 46, Iss. 6, pp. 2102-2119
Open Access | Times Cited: 5

Contrasting effects of intracellular and extracellular human PCSK9 on inflammation, lipid alteration and cell death
Aram Ghalali, Fahd Alhamdan, Swapna Upadhyay, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

Identification of key markers for the stages of nonalcoholic fatty liver disease: An integrated bioinformatics analysis and experimental validation
Itayetzi Reyes-Avendaño, Ana B. Villaseñor-Altamirano, Edilburga Reyes-Jiménez, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 11, pp. 1887-1896
Closed Access

Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access

Liver disease is a significant risk factor for cardiovascular outcomes - a UK Biobank study
Adriana Roca‐Fernández, Rajarshi Banerjee, Helena Thomaides‐Brears, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

Evaluation of Coronary Artery Disease Among Patients with Non-Alcoholic Fatty Liver Diseases Using Multislice C.T.
M.D. AHMED M. OSMAN AMANY M. RASHAD, M.Sc. MAHMOUD A. MARIE
The Medical Journal of Cairo University/˜The œMedical Journal of Cairo University (2022) Vol. 90, Iss. 3, pp. 583-591
Open Access

Page 1

Scroll to top